Larry L Wood bought $498K of PROCEPT BioRobotics (PRCT)
Executed Aug 7, disclosed Aug 10, 3 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 10), the stock returned +0.8% (delay-adjusted); from the execution session (Aug 7), +13.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Larry L Wood (President, CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Edwards Lifesciences Corporation (EW). Across 1 priced purchase filing, the average 21-session return was +13.6% from execution and +0.8% from disclosure (delay-adjusted; derived). The largest single filing was $498K of PRCT (23,900 sh × $20.85, as filed), executed Aug 7.
Healthcare · PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and interna…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→